Intellectual Property India Publishes Patent Application for 'Heterocyclic Compound Capable Of Inhibiting PRMT5*MTA And Use Thereof' Filed by Xizang Haisco Pharmaceutical Co. Ltd.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517006120 A) filed by Xizang Haisco Pharmaceutical Co. Ltd., Tibet, China, on Jan. 24, for 'heterocyclic compound capable of inhibiting prmt5*mta and use thereof.'

Inventor(s) include Li, Yao; Zhang, Haoliang; Shi, Zongjun; Wang, Jiancheng; Wang, Long; Gui, Naicheng; Zhao, Jingzheng; Huang, Shuai; Tang, Pingming; Zhang, Chen; and Yan, Pangke.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "A nitrogen-containing heterocyclic compound represented by formula (I-a), or a stereoisomer, a deuterated compound, a solvate, a pharmaceutically acceptabl...